[c09aa8]: / clusters / 9knumclustersv2 / clust_2322.txt

Download this file

18 lines (17 with data), 4.1 kB

 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
If female, may participate if not pregnant, not breastfeeding, and at least one of the following conditions apply: ) not a woman of childbearing potential (WOCBP); or ) a WOCBP who agrees to follow contraceptive guidance during the treatment period and for at least days after the last dose of study treatment.
If female, is not pregnant or breastfeeding, and agrees to use contraception during the treatment period and for ? days after last dose of study treatment.
A female participant is eligible to participate if she is not pregnant, not breastfeeding, and at least one of the following conditions applies: \r\n* Not a woman of childbearing potential (WOCBP) OR\r\n* A WOCBP who agrees to follow the contraceptive guidance during the treatment period and for at days after the last dose of study treatment. \r\n* Note: Abstinence is acceptable if this is the usual lifestyle and preferred contraception for the participant
Female participants who are not pregnant or breastfeeding, and who are either not a woman of childbearing potential (WOCBP), or are a WOCBP who agrees to use approved contraception during the treatment period and for at least days after the last dose of study treatment
A WOCBP who agrees to follow the contraceptive guidance in protocol during the treatment period and for at least days after the last dose of trial treatment.
Male or female subjects will be included. A female subject is eligible to participate if she is not pregnant, not breastfeeding, and at least of the following conditions applies: a) Not a woman of childbearing potential (WOCBP) OR b). A WOCBP who agrees to follow the contraceptive guidance during the treatment period and for at least days after the last dose of study treatment.
If of childbearing potential (male or female), agrees to practice an effective form of contraception during study treatment and for at least months following last treatment.
Female participants eligible to participate if not pregnant, not breastfeeding, and not a woman of childbearing potential (WOCBP) or is a WOCBP who agrees to follow contraceptive guidance during the treatment period and for ? days after the last dose of study treatment
A patient is eligible to participate if she is not pregnant, not breast-feeding, and at least one of the following conditions applies: a.) Not a woman of childbearing potential (WOCBP) OR b.) A WOCBP who agrees to follow the contraceptive guidance during the treatment period and for at least days after the last dose of study treatment
If of childbearing potential (male or female), agrees to use effective contraception during study treatment and for at least months following last treatment dose.
Male with female partner of childbearing potential agrees to use adequate method of contraception throughout study, until days after last dose of treatment or last blood draw
Female participants eligible to participate if not pregnant, not breastfeeding, and is not a woman of childbearing potential (WOCBP) or is a WOCBP who agrees to follow contraceptive guidance during the treatment period and for ? days after the last dose of study treatment
If of childbearing potential (male or female), agrees to practice an effective form of contraception during study treatment and for at least days following last treatment dose.
If of childbearing potential (male or female), agrees to practice an effective form of contraception during study treatment and for at least days following last treatment.
If of childbearing potential (male or female), agrees to practice an effective form of contraception during study treatment and for at least days following last treatment dose.
Female is not pregnant, and not breastfeeding; but if of childbearing potential agrees to follow contraceptive guidance during the treatment period and for at least weeks after the last dose of study treatment
If of childbearing potential (male or female), agrees to practice an effective form of contraception during study treatment and for at least months following last treatment.